obesity

Novo Nordisk pulls its FDA heart failure submission for Wegovy, will reapply early next year
Fierce Pharma
Wed, 08/7/24 - 11:47 am
Novo Nordisk
heart failure
obesity
Wegovy
FDA
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Motley Fool
Sun, 08/4/24 - 06:30 pm
AstraZeneca
Pharma CEOs
weight loss
obesity
Pascal Soriot
Pfizer’s Bourla confident in company’s obesity drug position, despite delays
Pharma Voice
Thu, 08/1/24 - 11:14 am
Pfizer
Pharma CEOs
Albert Bourla
obesity
GLP-1 drugs are driving up healthcare costs
Medical Marketing and Media
Fri, 07/26/24 - 11:03 am
obesity
weight loss
GLP-1 agonist
healthcare costs
Eli Lily
Novo Nordisk
Wegovy
Zepbound
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
BioPharma Dive
Thu, 07/25/24 - 10:05 pm
Roche
obesity
Carmot Therapeutics
CT-388
CT-996
Viking shares jump on plans to speed obesity drug into late-stage testing
BioPharma Dive
Thu, 07/25/24 - 11:23 am
Viking Therapeutics
obesity
clinical trials
VK2735
Novo Nordisk's Wegovy gets UK approval for lowering heart risks
Reuters
Tue, 07/23/24 - 11:24 am
Novo Nordisk
UK
Wegovy
heart disease
stroke
obesity
Innovent’s Lilly-Partnered Type 2 Diabetes Drug Aces Phase III in China, Inches Closer to Approval
BioSpace
Mon, 07/22/24 - 06:50 pm
Innovent Biologics
mazdutide
obesity
China
Eli Lilly
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers
Yahoo/Raleigh News & Observer
Mon, 07/22/24 - 06:48 pm
Novo Nordisk
Eli Lilly
obesity
Wegovy
Zepbound
North Carolina
Medicaid
5 startups looking to compete in the obesity space
BioSpace
Mon, 07/22/24 - 12:03 pm
startups
obesity
weight loss
Metsera
35Pharma
ProFound Therapeutics
Metaphore
EraCal Therapeutics
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
Motley Fool
Sun, 07/21/24 - 11:02 pm
Pfizer
obesity
weight loss
‘Not prudent’ for Novartis to join GLP-1 obesity race as late-runner, says CEO
Fierce Biotech
Thu, 07/18/24 - 11:13 pm
Novartis
Pharma CEOs
obesity
Vas Narasimhan
GLP-1 agonists
Roche reports positive data from Phase I obesity treatment trial
Clinical Trials Arena
Wed, 07/17/24 - 12:18 pm
Roche
CT-996
clinical trials
obesity
Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts
Fierce Pharma
Fri, 07/12/24 - 11:33 am
obesity
diabetes
oncology
Novo Nordisk
Eli Lilly
Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering
Fierce Biotech
Fri, 07/12/24 - 11:14 am
Pfizer
obesity
danuglipron
Viking Therapeutics
Terns Pharmaceuticals
Vivani to start in-human trial for GLP-1 implant for treating obesity
Clinical Trials Arena
Fri, 07/12/24 - 11:08 am
Vivani Medical
clinical trials
GLP-1 implant
obesity
Weight-loss drugs could become a test case for AI
Axios
Tue, 07/9/24 - 09:24 pm
artificial intelligence
weight loss
obesity
GLP-1 agonist
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
BioSpace
Mon, 07/8/24 - 11:49 am
GLP-1
Ozempic
Novo Nordisk
Eli Lilly
obesity
cancer
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Boehringer Ingelheim
Gubra
clinical trials
BI 3034701
obesity
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Reuters
Mon, 07/1/24 - 09:52 pm
Eli Lilly
Mounjaro
India
obesity

Pages